While in the Medical Department in large Pharma he held the positions of; Director of Clinical Operations, International Clinical Research and Development, Medical Research Scientist, and also as VP of an Oncology Division. During his career he directed and contributed to the activities of over 125 Canadian and international multi-center (Phase I-IIIb) clinical trials, resulting in the introduction of several new cancer drugs and indications. He also contributed to several Investigational New Drug (IND) submissions dossier evaluations to Health Authorities.

His oncology disease sites expertise includes: Breast, Prostate, Colorectal, Leukemia (CML, CLL, NHL, AML), Lung, Liver, Ovarian, Renal and several others.

As the Director of the Prescription Drug Program and Medicare at the Department Health & Wellness, at the Government in the Province of New Brunswick (NB) in Canada, he provided Direction and Guidance to Elected Premier and Minister of Health, on all issues relating to Prescription Drug Program (PDP) / Medicare while ensuring that entitled health services provided by thousands of physicians, pharmacists were accessible to the population.